1273119

Cyrus Desouza — FEI 3013090931

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Omaha, NE (United States)

Additional Details

Clinical Investigator (CI)